Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Symptoms and Cluster Influences

F. Pérez-López, P. Chedraui, G. Pérez-Roncero, M. T. López-Baena, J. L. Cuadros-López
{"title":"Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Symptoms and Cluster Influences","authors":"F. Pérez-López, P. Chedraui, G. Pérez-Roncero, M. T. López-Baena, J. L. Cuadros-López","doi":"10.2174/1874354400903010039","DOIUrl":null,"url":null,"abstract":"Many women in their reproductive years experience some mood, behavioral, or physical symptoms in the week prior to menses. Women experiencing mild symptoms may have a wide variability in the level of symptom burden, whereas a minority suffers severe and debilitating symptoms. Severe premenstrual syndrome (PMS) affects 3% to 5% of women of reproductive age and has been classified under the Diagnostic and Statistical Manual of Mental Disorders (DSM IV) as premenstrual dysphoric disorder (PMDD). Both disorders are characterized mainly by symptoms confined to the premenstrual period, which reduce not only patients' quality of life, but also their working activities. Women suffering PMDD experience severe dysphoric mood, and a greater desire and actual intake of certain foods, demonstrating impaired cognitive performance during the luteal phase. Several theories have been proposed to explain the underlying mechanisms of PMS and PMDD with complex bio-psycho-social factors involved. Although precise causes are unknown, the late luteal phase could be associated with diverse psychosomatic and behavioral symptoms appearing premenstrually which should be appropriately treated. Notwithstanding this high prevalence, no specific symptoms or signs appear, nor have any recognizable anatomical factors been identified in women suffering PMS or PMDD, and hence, no universal treatment yet exists. Despite this, therapeutic progress has been reached, although the ideal treatment has not yet been obtained due to the many clusters involved.","PeriodicalId":88755,"journal":{"name":"The open psychiatry journal","volume":"17 1","pages":"39-49"},"PeriodicalIF":0.0000,"publicationDate":"2009-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"26","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The open psychiatry journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874354400903010039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 26

Abstract

Many women in their reproductive years experience some mood, behavioral, or physical symptoms in the week prior to menses. Women experiencing mild symptoms may have a wide variability in the level of symptom burden, whereas a minority suffers severe and debilitating symptoms. Severe premenstrual syndrome (PMS) affects 3% to 5% of women of reproductive age and has been classified under the Diagnostic and Statistical Manual of Mental Disorders (DSM IV) as premenstrual dysphoric disorder (PMDD). Both disorders are characterized mainly by symptoms confined to the premenstrual period, which reduce not only patients' quality of life, but also their working activities. Women suffering PMDD experience severe dysphoric mood, and a greater desire and actual intake of certain foods, demonstrating impaired cognitive performance during the luteal phase. Several theories have been proposed to explain the underlying mechanisms of PMS and PMDD with complex bio-psycho-social factors involved. Although precise causes are unknown, the late luteal phase could be associated with diverse psychosomatic and behavioral symptoms appearing premenstrually which should be appropriately treated. Notwithstanding this high prevalence, no specific symptoms or signs appear, nor have any recognizable anatomical factors been identified in women suffering PMS or PMDD, and hence, no universal treatment yet exists. Despite this, therapeutic progress has been reached, although the ideal treatment has not yet been obtained due to the many clusters involved.
经前综合征和经前烦躁障碍:症状和群集影响
许多处于生育年龄的女性在月经前一周会经历一些情绪、行为或身体上的症状。出现轻微症状的妇女在症状负担水平上可能有很大差异,而少数妇女则出现严重和使人衰弱的症状。严重经前综合症(PMS)影响3%至5%的育龄妇女,根据《精神疾病诊断和统计手册》(DSM IV),它被归类为经前焦虑症(PMDD)。这两种疾病的主要特征是症状局限于经前期,这不仅降低了患者的生活质量,而且降低了他们的工作活动。患有经前不悦症的女性会经历严重的烦躁情绪,对某些食物的欲望和实际摄入量更大,在黄体期表现出认知能力受损。人们提出了几种理论来解释经前症候群和经前不悦症的潜在机制,其中涉及复杂的生物、心理和社会因素。虽然确切的原因尚不清楚,但黄体期晚期可能与经前出现的各种心身和行为症状有关,应适当治疗。尽管发病率很高,但在患有经前症候群或经前不悦症的妇女身上没有出现具体的症状或体征,也没有发现任何可识别的解剖学因素,因此,目前还没有普遍的治疗方法。尽管如此,治疗已经取得了进展,尽管由于涉及许多簇,尚未获得理想的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信